Targeting the IL-12/IL-23 axis: An alternative approach to removing tumor induced immune suppression

por Smyth, Mark J, Teng, Michele W L
Publicado 2014

Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?

por O’Donnell, Jake S., Smyth, Mark J., Teng, Michele W. L.
Publicado 2016

PD1 functions by inhibiting CD28-mediated co-stimulation

por O'Donnell, Jake S, Smyth, Mark J, Teng, Michele W L
Publicado 2017

The interaction between murine melanoma and the immune system reveals that prolonged responses predispose for autoimmunity

por Ngiow, Shin Foong, von Scheidt, Bianca, Möller, Andreas, Smyth, Mark J., Teng, Michele W. L.
Publicado 2013

TIM3(+)FOXP3(+) regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer

por Sakuishi, Kaori, Ngiow, Shin Foong, Sullivan, Jenna M., Teng, Michele W. L., Kuchroo, Vijay K., Smyth, Mark J., Anderson, Ana C.
Publicado 2013

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multi...

por Ahern, Elizabeth, Cubitt, Annette, Ballard, Emma, Teng, Michele W. L., Dougall, William C., Smyth, Mark J., Godbolt, David, Naidoo, Rishendran, Goldrick, Amanda, Hughes, Brett G. M.
Publicado 2019

Cancer immunoediting by the innate immune system in the absence of adaptive immunity

por O’Sullivan, Timothy, Saddawi-Konefka, Robert, Vermi, William, Koebel, Catherine M., Arthur, Cora, White, J. Michael, Uppaluri, Ravi, Andrews, Daniel M., Ngiow, Shin Foong, Teng, Michele W.L., Smyth, Mark J., Schreiber, Robert D., Bui, Jack D.
Publicado 2012

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms

por Li, Xian-Yang, Das, Indrajit, Lepletier, Ailin, Addala, Venkateswar, Bald, Tobias, Stannard, Kimberley, Barkauskas, Deborah, Liu, Jing, Aguilera, Amelia Roman, Takeda, Kazuyoshi, Braun, Matthias, Nakamura, Kyohei, Jacquelin, Sebastien, Lane, Steven W., Teng, Michele W.L., Dougall, William C., Smyth, Mark J.
Publicado 2022

ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis

por Nalkurthi, Christina, Schroder, Wayne A., Melino, Michelle, Irvine, Katharine M., Nyuydzefe, Melanie, Chen, Wei, Liu, Jing, Teng, Michele W.L., Hill, Geoffrey R., Bertolino, Patrick, Blazar, Bruce R., Miller, Gregory C., Clouston, Andrew D., Zanin-Zhorov, Alexandra, MacDonald, Kelli P.A.
Publicado 2021

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd–5th, 2020, Italy)

por Ascierto, Paolo A., Blank, Christian, Dummer, Reinhard, Ernstoff, Marc S., Ferrone, Soldano, Fox, Bernard A., Gajewski, Thomas F., Garbe, Claus, Hwu, Patrick, Kalinski, Pawel, Krogsgaard, Michelle, Lo, Roger S., Luke, Jason J., Neyns, Bart, Postow, Michael A., Quezada, Sergio A., Teng, Michele W. L., Trinchieri, Giorgio, Testori, Alessandro, Caracò, Corrado, Osman, Iman, Puzanov, Igor, Thurin, Magdalena
Publicado 2021

Donor colonic CD103(+) dendritic cells determine the severity of acute graft-versus-host disease

por Koyama, Motoko, Cheong, Melody, Markey, Kate A., Gartlan, Kate H., Kuns, Rachel D., Locke, Kelly R., Lineburg, Katie E., Teal, Bianca E., Leveque-El mouttie, Lucie, Bunting, Mark D., Vuckovic, Slavica, Zhang, Ping, Teng, Michele W.L., Varelias, Antiopi, Tey, Siok-Keen, Wockner, Leesa F., Engwerda, Christian R., Smyth, Mark J., Belz, Gabrielle T., McColl, Shaun R., MacDonald, Kelli P.A., Hill, Geoffrey R.
Publicado 2015